Skip to main content

Sage Therapeutics stock bounces 50% after positive results for depression treatment

The therapy failed in a different disease area in September. Now, it’s having an improbable comeback.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.